Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Deregulation of HOX genes by DNMT3A and MLL mutations converges on BMI1

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Yang L, Rau R, Goodell MA . DNMT3A in haematological malignancies. Nat Rev Cancer 2015; 15: 152–165.

    Article  CAS  Google Scholar 

  2. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010; 363: 2424–2433.

    Article  CAS  Google Scholar 

  3. Yan XJ, Xu J, Gu ZH, Pan CM, Lu G, Shen Y et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet 2011; 43: 309–315.

    Article  CAS  Google Scholar 

  4. Xu J, Wang YY, Dai YJ, Zhang W, Zhang WN, Xiong SM et al. DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression/DNA methylation in hematopoietic cells. Proc Natl Acad Sci USA 2014; 111: 2620–2625.

    Article  CAS  Google Scholar 

  5. Shen Y, Zhu YM, Fan X, Shi JY, Wang QR, Yan XJ et al. Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia. Blood 2011; 118: 5593–5603.

    Article  CAS  Google Scholar 

  6. Muntean AG, Hess JL . The pathogenesis of mixed-lineage leukemia. Annu Rev Pathol 2012; 7: 283–301.

    Article  CAS  Google Scholar 

  7. Hanson RD, Hess JL, Yu BD, Ernst P, van Lohuizen M, Berns A et al. Mammalian trithorax and polycomb-group homologues are antagonistic regulators of homeotic development. Proc Natl Acad Sci USA 1999; 96: 14372–14377.

    Article  CAS  Google Scholar 

  8. Xia ZB, Anderson M, Diaz MO, Zeleznik-Le NJ . MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc Natl Acad Sci USA 2003; 100: 8342–8347.

    Article  CAS  Google Scholar 

  9. Negishi M, Saraya A, Miyagi S, Nagao K, Inagaki Y, Nishikawa M et al. Bmi1 cooperates with Dnmt1-associated protein 1 in gene silencing. Biochem Biophys Res Commun 2007; 353: 992–998.

    Article  CAS  Google Scholar 

  10. So CW, Lin M, Ayton PM, Chen EH, Cleary ML . Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell 2003; 4: 99–110.

    Article  CAS  Google Scholar 

  11. Valtieri M, Tweardy DJ, Caracciolo D, Johnson K, Mavilio F, Altmann S et al. Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol 1987; 138: 3829–3835.

    CAS  PubMed  Google Scholar 

  12. Cao R, Tsukada Y, Zhang Y . Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell 2005; 20: 845–854.

    Article  CAS  Google Scholar 

  13. Smith LL, Yeung J, Zeisig BB, Popov N, Huijbers I, Barnes J et al. Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells. Cell Stem Cell 2011; 8: 649–662.

    Article  CAS  Google Scholar 

  14. Yuan J, Takeuchi M, Negishi M, Oguro H, Ichikawa H, Iwama A . Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells. Leukemia 2011; 25: 1335–1343.

    Article  CAS  Google Scholar 

  15. Liu H, Westergard TD, Cashen A, Piwnica-Worms DR, Kunkle L, Vij R et al. Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4. Cancer Cell 2014; 25: 530–542.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Special thanks are due to Dr Yuet W Kan (UCSF) for his kind support to this project. We also thank Dr Scott C Kogan (UCSF) for providing 32D cells. This work was supported by the Chinese National Key Basic Research Project (973: 2013CB966800) to S-JC and HL, the National Natural Science Foundation of China (81370651 and 81570119) to HL, the Thousand Young Talents program of China to HL, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (2012-70) to HL, the Shu Guang project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (14SG15) to HL and the American Society of Hematology Scholar Award to HL.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to S-J Chen or H Liu.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tan, YT., Sun, Y., Zhu, SH. et al. Deregulation of HOX genes by DNMT3A and MLL mutations converges on BMI1. Leukemia 30, 1609–1612 (2016). https://doi.org/10.1038/leu.2016.15

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2016.15

This article is cited by

Search

Quick links